Targeted drug therapy: The platelet side

Author： Lhermusier T.   Van Rothem J.   Garcia C.   Gratacap M.P.   Payrastre B.  

Publisher： Informa Healthcare

ISSN： 1369-1635

Source： Platelets, Vol.22, Iss.7, 2011-11, pp. : 479-484

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mean platelet volume reproducibility and association with platelet activity and anti-platelet therapy

By Shah Binita   Valdes Vanessa   Nardi Michael A.   Hu Liang   Schrem Ezra   Berger Jeffrey S.  

Platelets, Vol. 25, Iss. 3, 2014-05 ,pp. : 188-192

Informa Healthcare

Access to resources Recommend Favorite

A paradigm shift in anti-platelet therapy?

By Bonello L.   Barragan P.   Paganelli F.  

Platelets, Vol. 19, Iss. 8, 2008-12 ,pp. : 562-564

Informa Healthcare

Access to resources Recommend Favorite

Role of anthracyclines in the era of targeted therapy

By Cortés-Funes Hernán   Coronado Cyntia  

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 56-60

Humana Press, Inc

Access to resources Recommend Favorite

Platelet Inhibitor Therapy: Mechanisms of Action and Clinical Use

By Michelson Alan D.  

Journal of Thrombosis and Thrombolysis, Vol. 16, Iss. 1-2, 2003-08 ,pp. : 13-15

Springer Publishing Company

Access to resources Recommend Favorite

Platelet reactivity and nonresponse to dual antiplatelet therapy: A review

By Vila Peter M.   Zafar M. Urooj   Badimon Juan J.  

Platelets, Vol. 20, Iss. 8, 2009-08 ,pp. : 531-538

Informa Healthcare

Access to resources Recommend Favorite